Centrum Medyczne All-Med Badania Kliniczne
- Address
- lock Available on a paid plan
Immune System Diseases
The research program focuses on psoriatic arthritis and other autoimmune disorders, aiming to test innovative biologic agents and improve long‑term disease control.
- Psoriatic Arthritis
- Rheumatoid Arthritis
- Systemic Lupus Erythematosus
- Plaque Psoriasis
- Genital Psoriasis
Centrum Medyczne All-Med Badania Kliniczne collaborates with academic partners to advance therapeutic options for patients with immune‑mediated disease.
Musculoskeletal Diseases
Studies target joint inflammation in conditions such as rheumatoid arthritis, evaluating new treatments to preserve mobility and reduce pain.
- Rheumatoid Arthritis
- Psoriatic Arthritis
- Active Psoriatic Arthritis
- Moderately Active Rheumatoid Arthritis
- Joint Damage Assessment
The site’s multidisciplinary team integrates rheumatology expertise to support trials that may change standard care.
Nutritional and Metabolic Diseases
Research includes patients with obesity and type 2 diabetes, seeking therapies that improve glycaemic control and support weight reduction.
- Obesity
- Obesity without Type 2 Diabetes
- Type 2 Diabetes
- Weight Loss with Tirzepatide Combination
Collaboration with endocrinology specialists allows comprehensive evaluation of metabolic outcomes at the Cracow facility.
Otorhinolaryngologic Diseases
Clinical work investigates chronic rhinosinusitis with nasal polyps and related sinonasal conditions, testing novel intranasal agents to relieve congestion and improve quality of life.
- Chronic Rhinosinusitis with Nasal Polyps
- Chronic Rhinosinusitis without Nasal Polyps
- Nasal Polyps
- Nasal Congestion
The centre’s otolaryngology unit provides endoscopic expertise essential for these trials.
Respiratory Tract Diseases
The program addresses asthma and chronic obstructive pulmonary disease, focusing on reducing exacerbations and enhancing lung function through targeted therapies.
- Asthma
- Severe Eosinophilic Asthma
- Moderate-to-severe Asthma
- Chronic Obstructive Pulmonary Disease
- COPD Exacerbations
Pulmonology specialists at the site conduct rigorous safety monitoring to support respiratory drug development.
Skin and Connective Tissue Diseases
Trials explore treatments for atopic dermatitis, chronic urticaria, and psoriasis, aiming to reduce itch, inflammation, and skin lesions.
- Atopic Dermatitis
- Chronic Spontaneous Urticaria
- Pruritus of Unknown Origin
- Plaque Psoriasis
- Genital Psoriasis
Dermatology clinicians collaborate with immunologists to evaluate both systemic and topical interventions.
Immune System Phenomena
Research examines immune system phenomena such as cytokine signaling and cellular activation to understand how novel agents modulate inflammation.
- Cytokine Inhibition
- Immune Cell Activation
- Biologic Response Modulation
- Inflammatory Pathway Targeting
Insights from these studies support the development of next‑generation immunotherapies across multiple disease areas.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Top 4 of 6 therapeutic areas and 15 of 65 IMPs, ranked by number of trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Top 40 of 61 compounds, ranked by number of trials.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 14 by active trials.
lock +13 more on a paid plan
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
lock +16 more on a paid plan
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 1 624 other sites in Poland
Therapeutic Area Benchmark — Poland
Select a therapeutic area to compare against other sites in Poland.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Poland
Market Share
Country: Poland
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Centrum Medyczne All-Med Badania Kliniczne
lock Showing 1 of 71 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| A 2-year Open-label Extension Study to Assess the Long-term Safety and Efficacy of Lebrikizumab in Adult and Adolescent Patients with Moderate-to-Severe Atopic Dermatitis | Almirall S.A. | Phase III | Not Recruiting | May 2023 | Apr 2026 |
IMP list
lock Showing 1 of 65 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Human Igg1 Kappa Monoclonal Antibody Against Crlf2 | 4 | Unknown | 2024-06-19 | 2025-10-20 |
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.